Isadora Sena

Mrs. Isadora Sena


Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2017 in Developmental Biology
Verified
Journal Article
Closed access
PPPedro Henrique Dias Moura Prazeres
Pedro Henrique Dias Moura Prazeres
ISIsadora Sena
Isadora Sena
IBIsabella da Terra Borges
Isabella da Terra Borges
PAPatrick Orestes de Azevedo
Patrick Orestes de Azevedo
JAJulia Peres Andreotti
Julia Peres Andreotti
Alexander BirbrairAlexander Birbrair
Alexander Birbrair

20 July 2020 in Journal of Cellular and Molecular Medicine
Verified
Journal Article
Open access
PDF file
PPPedro H. D. M. Prazeres
Pedro H. D. M. Prazeres
CLCaroline Leonel
Caroline Leonel
WSWalison N. Silva
Walison N. Silva
BRBeatriz G. S. Rocha
Beatriz G. S. Rocha
GSGabryella S. P. Santos
Gabryella S. P. Santos
Alexander BirbrairAlexander Birbrair
Alexander Birbrair
The tumour mass is composed not only of heterogeneous neoplastic cells, but also a variety of other components that may affect cancer cells behaviour. The lack of detailed knowledge about all the constituents of the tumour microenvironment restricts the design of effective treatments. Nerves have been reported to contribute to the growth and maintenance of numerous tissues. The effects of sensory innervations on tumour growth remain unclear. Here, by using state‐of‐the‐art techniques, including Cre/loxP technologies, confocal microscopy, in vivo‐tracing and chemical denervation, we revealed the presence of sensory nerves infiltrating within the melanoma microenvironment, and affecting cancer progression. Strikingly, melanoma growth in vivo was accelerated following genetic ablation or chemical denervation of sensory nerves. In humans, a retrospective analysis of melanoma patients revealed that increased expression of genes related to sensory nerves in tumours was associated with better clinical outcomes. These findings suggest that sensory innervations counteract melanoma progression. The emerging knowledge from this research provides a novel target in the tumour microenvironment for therapeutic benefit in cancer patients.

31 May 2018 in Cancer Research
Verified
Journal Article
Open access
PDF file
APAna E. Paiva
Ana E. Paiva
LLLuiza Lousado
Luiza Lousado
DGDaniel A.P. Guerra
Daniel A.P. Guerra
PAPatrick O. Azevedo
Patrick O. Azevedo
ISIsadora Sena
Isadora Sena
Alexander BirbrairAlexander Birbrair
Alexander Birbrair
The premetastatic niche formed by primary tumor–derived molecules contributes to fixation of cancer metastasis. The design of efficient therapies is limited by the current lack of knowledge about the details of cellular and molecular mechanisms involved in the premetastatic niche formation. Recently, the role of pericytes in the premetastatic niche formation and lung metastatic tropism was explored by using state-of-the-art techniques, including in vivo lineage-tracing and mice with pericyte-specific KLF4 deletion. Strikingly, genetic inactivation of KLF4 in pericytes inhibits pulmonary pericyte expansion and decreases metastasis in the lung. Here, we summarize and evaluate recent advances in the understanding of pericyte contribution to premetastatic niche formation. Cancer Res; 78(11); 2779–86. ©2018 AACR.

1 July 2017 in Stem Cell Reviews and Reports
Verified
Journal Article
Closed access
PDF file
IBIsabella Borges
Isabella Borges
ISIsadora Sena
Isadora Sena
PAPatrick Azevedo
Patrick Azevedo
JAJulia Andreotti
Julia Andreotti
VAViviani Mendes de Almeida
Viviani Mendes de Almeida
Alexander BirbrairAlexander Birbrair
Alexander Birbrair

25 February 2018 in Cancer Medicine
Verified
Journal Article
Open access
PDF file
ISIsadora Sena
Isadora Sena
APAna E. Paiva
Ana E. Paiva
PPPedro H. D. M. Prazeres
Pedro H. D. M. Prazeres
PAPatrick O. Azevedo
Patrick O. Azevedo
LLLuiza Lousado
Luiza Lousado
Alexander BirbrairAlexander Birbrair
Alexander Birbrair
Glioblastoma multiforme is the most common and aggressive primary brain tumor, with an extremely poor prognosis. The lack of detailed knowledge about the cellular and molecular mechanisms involved in glioblastoma development restricts the design of efficient therapies. A recent study using state‐of‐art technologies explores the role of pericytes in the glioblastoma microenvironment. Glioblastoma‐activated pericytes develop an immunosuppressive phenotype, reducing T‐cell activation through the induction of an anti‐inflammatory response. Strikingly, pericytes support glioblastoma growth in vitro and in vivo. Here, we describe succinctly the results and implications of the findings reported in pericytes' and glioblastomas' biology. The emerging knowledge from this study will be essential for the treatment of brain tumors.

15 July 2017 in Stem Cells and Development
Verified
Journal Article
Closed access
Alexander BirbrairAlexander Birbrair
Alexander Birbrair
IBIsabella da Terra Borges
Isabella da Terra Borges
ISIsadora Sena
Isadora Sena
GAGregório Guilherme Almeida
Gregório Guilherme Almeida
LMLindolfo da Silva Meirelles
Lindolfo da Silva Meirelles
ODOsvaldo Delbono
Osvaldo Delbono
Pericytes are defined by both their anatomical location and molecular markers. Numerous publications have reported their role as stem cells, contributing to the formation of tissues other than blood vessels. However, using cell-lineage tracing in a new transgenic mouse model, a recent study shows that in the context of aging and some pathologies, Tbx18+ pericytes do not function as stem cells in vivo. This study challenges the current view that pericytes can differentiate into other cells and reopen questions about their plasticity. This emerging knowledge is important not only for our understanding of development but may also inform treatments for diseases.